EN
HI
Kwality Pharmaceuticals Share price
3361.1
269.20 (-7.42%)NSE
BSE
Last updated on 21 Aug, 2026 | 15:57 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Kwality Pharmaceuticals share price chart
Kwality Pharmaceuticals Share Key Metrics
Volume
1.14 L
Market Cap
3487.54 CR
LTQ@LTP
15@3361.10
ATP
3405.12
Var Margin
28.01 %
Circuit Range
2688.9-4033.3
Delivery %
40.58 %
Value
38.73 CR
ASM/GSM
No
Market Lot
1
Summary
KPL stock price is ₹3361.1 as of 22 Aug, 2026. The stock intraday movement has stayed between ₹3327.00 and ₹3634.50, while Kwality Pharmaceuticals share price 52 week high low is ₹1561.00 & ₹3744.00.
In terms of trading activity, KPL share price has recorded a volume of 1,13,735 shares. The Kwality Pharmaceuticals has a market cap of ₹10376198. The stock’s Average Traded Price (ATP) stands at ₹3405.12, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 15 @ ₹3361.10.
The Kwality Pharmaceuticals upper circuit limit is ₹4033.30 & The Kwality Pharmaceuticals lower circuit limit is ₹2688.90, with a Value of ₹38.73 CR. The Delivery Percentage for the day is 40.58%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Kwality Pharmaceuticals Resistance and Support
Pivot 3604.63
Resistance
First Resistance
3734.56
Second Resistance
3838.83
Third Resistance
3968.76
Support
First Support
3500.36
Second Support
3370.43
Third Support
3266.16
Kwality Pharmaceuticals Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
54.86%
Mutual Fund
0%
Insurance
0%
Foreign Institutional Investors
3.13%
Domestic Institutional Investors
0.56%
Retail
41.44%
Others
0.01%
Total Promoters
MAR '26
54.87%
JUN '26
54.86%
Kwality Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-10 | Quarterly Results |
| 2026-05-19 | Audited Results |
| 2026-02-12 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-11 | Quarterly Results |
| 2025-05-19 | Audited Results |
| 2025-01-31 | Quarterly Results |
| 2024-10-30 | Quarterly Results |
| 2024-08-10 | Quarterly Results |
Kwality Pharmaceuticals News
Kwality Pharmaceuticals Ltd - 539997 - Board Meeting Outcome for Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30.06.2026 Under Regulation 33 Of The SEBI (LODR) Regulations, 2015
Kwality Pharmaceuticals reported robust Q1 FY27 cons. financial results, with revenue growing 46% YoY to ₹162 crore and net profit soaring 119% YoY to ₹26 crore. The company also secured 15+ new product registrations across Malaysia, Algeria, Peru, and Mexico, reflecting strong operational expansion.
Aug 10 2026 12:09:57
Kwality Pharmaceuticals Ltd - 539997 - Board Meeting Outcome for Board Meeting Outcome For Intimation Of AGM
Kwality Pharma's Board has re-appointed Mr. Aditya Arora as Whole Time Director for a further five-year term. His new tenure will commence on September 30, 2026, subject to shareholder approval at the upcoming AGM.
Aug 08 2026 20:25:03
Kwality Pharmaceuticals Ltd - 539997 - Board Meeting Intimation for Consideration And Approval Of Standalone & Consolidated Unaudited Financial Results For The Quarter Ended 30-06-2026.
Kwality Pharmaceuticals board will hold a meeting on August 10, 2026. The agenda includes considering and approving the financial results for the first quarter of FY27, ended June 30, 2026.
Aug 03 2026 15:50:23
Kwality Pharmaceuticals Ltd - 539997 - Disclosure Under Regulation 30 Of SEBI LODR
Kwality Pharmaceuticals received permission from CDSCO to manufacture pilot batches of Pembroluzimab for preclinical studies. This approval advances the biologics product from the research and development stage to the preclinical stage.
Jul 24 2026 10:06:59
Read More
Kwality Pharmaceuticals Management
| Name | Position |
|---|---|
| Gurpreet Kaur | Company Secretary & Compliance Officer |
| Ramesh Kumar | Managing Director |
Kwality Pharmaceuticals Similar Stocks
Gufic Biosciences Ltd.
431.50
17.80 (4.30%)
Indraprastha Medical Corporation Ltd.
369.70
-7.10 (1.88%)
Aarti Drugs Ltd.
417.40
2.65 (0.64%)
Unichem Laboratories Ltd.
526.15
9.60 (1.86%)
Advanced Enzyme Technologies Ltd.
300.00
-3.00 (0.99%)
SMS Pharmaceuticals Ltd.
356.60
0.10 (0.03%)
Ind-Swift Laboratories Ltd.
329.59
-3.92 (1.18%)
Dishman Carbogen Amcis Ltd.
173.54
1.13 (0.66%)
Beta Drugs Ltd.
2327.70
32.70 (1.42%)
Kwality Pharmaceuticals FAQs
The Buying Price of Kwality Pharmaceuticals share is 3361.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Kwality Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Kwality Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Kwality Pharmaceuticals shares is 42.98. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Kwality Pharmaceuticals shares is 9.77. Useful to assess the stock's value relative to its book value.
To assess Kwality Pharmaceuticals’s valuation compare Sector P/E, P/B which are 68.51 & 3.35 with sector averages, along with growth rates and financial metrics.
The Market Cap of Kwality Pharmaceuticals is 3487.54 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Kwality Pharmaceuticals share price is 3744.00 & 1561.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Kwality Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in KPL
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC